168 related articles for article (PubMed ID: 2445813)
1. Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analogues.
Taylor-Papadimitriou J; Shearer M; Griffin D
J Immunol; 1987 Nov; 139(10):3375-81. PubMed ID: 2445813
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers.
Shearer M; Taylor-Papadimitriou J; Griffin D; Balkwill F
J Immunol; 1984 Dec; 133(6):3096-101. PubMed ID: 6491281
[TBL] [Abstract][Full Text] [Related]
3. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors.
Kandefer-Szerszeń M; Lundgren E
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):241-6. PubMed ID: 1284462
[TBL] [Abstract][Full Text] [Related]
4. Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach.
Russell JK; Hayes MP; Carter JM; Torres BA; Dunn BM; Russell SW; Johnson HM
J Immunol; 1986 May; 136(9):3324-8. PubMed ID: 2420886
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of four monoclonal antibodies specific for human interferon-alpha-1 and -alpha-2.
Noll F; Handschack W; Eichmann E; Gaestel M; Schneider F; Kuhl R; Löster K
Biomed Biochim Acta; 1989; 48(1):165-76. PubMed ID: 2775248
[TBL] [Abstract][Full Text] [Related]
6. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
8. Reduced receptor binding by a human interferon-gamma fragment lacking 11 carboxyl-terminal amino acids.
Leinikki PO; Calderon J; Luquette MH; Schreiber RD
J Immunol; 1987 Nov; 139(10):3360-6. PubMed ID: 2960733
[TBL] [Abstract][Full Text] [Related]
9. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.
Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT
Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313
[TBL] [Abstract][Full Text] [Related]
10. Mapping of an epitope of human leukocyte alpha interferon A which is recognized by the murine monoclonal antibody NK2.
Alexenko AP; Izotova LS; Kostrov SV; Strongin AYa
Biomed Sci; 1991; 2(4):403-9. PubMed ID: 1724609
[TBL] [Abstract][Full Text] [Related]
11. Localization of the receptor binding site of IFN-alpha 2b.
Siemers R; Hensley L; Ozer H
J Immunol; 1988 Sep; 141(5):1550-5. PubMed ID: 2970505
[TBL] [Abstract][Full Text] [Related]
12. Receptors for human interferon alpha on bovine cells: specificity and tissue distribution.
Chambers PJ; Saltis J; Alin P; Wright A; Linnane AW; Cheetham BF
Immunopharmacol Immunotoxicol; 1990; 12(3):513-25. PubMed ID: 2148343
[TBL] [Abstract][Full Text] [Related]
13. [Limited proteolysis of human leukocyte interferon-alpha2 and localization of the antigenic determinant binding the monoclonal antibodies].
Kostrov SV; Chernovskaia TV; Khodova OM; Borukhov SI; Ryzhavskaia AS
Biokhimiia; 1985 Nov; 50(11):1859-65. PubMed ID: 2415171
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analysis of human IFN-alpha. Mapping of a conformational epitope by homologue scanning.
Wang L; Hertzog PJ; Galanis M; Overall ML; Waine GJ; Linnane AW
J Immunol; 1994 Jan; 152(2):705-15. PubMed ID: 7506733
[TBL] [Abstract][Full Text] [Related]
15. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
Bidart JM; Ozturk M; Bellet DH; Jolivet M; Gras-Masse H; Troalen F; Bohuon CJ; Wands JR
J Immunol; 1985 Jan; 134(1):457-64. PubMed ID: 2578049
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha.
Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I
Immunology; 1991 May; 73(1):8-11. PubMed ID: 1710604
[TBL] [Abstract][Full Text] [Related]
17. Epitope localization of a monoclonal antibody, LO-22, with broad specificity for interferon-alpha subtypes.
Meager A; Berg K
J Interferon Res; 1986 Dec; 6(6):729-36. PubMed ID: 2437225
[TBL] [Abstract][Full Text] [Related]
18. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
[TBL] [Abstract][Full Text] [Related]
19. Modification of the antigenic structure of human interferon alpha-2 by PH 2 treatment: a further support for the antigenic relationship between alpha and beta interferons.
Kontsek P; Borecký L; Koniseková E; Novák M; Krchnák V
Acta Virol; 1990 Apr; 34(2):145-54. PubMed ID: 1698015
[TBL] [Abstract][Full Text] [Related]
20. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
